ArticleMolecular therapy. Oncology2024

An oncolytic HAdV-5 with reduced surface charge combines diminished toxicity and improved tumor targeting.

Frederik Wienen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.